Diasorin | DIA - Operating Expenses

Stock Price
74.59
Daily Change
0.27 0.36%
Monthly
7.11%
Yearly
-27.48%
Q1 Forecast
70.01

Diasorin reported EUR224.05M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Amplifon EUR 539.04M 16.22M Sep/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Brookdale Senior Living USD -6.73M 759.01M Sep/2025
Cencora USD 82.77B 3.09B Sep/2025
Diasorin EUR 224.05M 6.89M Sep/2025
Encompass Health USD 1.23B 35.3M Sep/2025
Enovis USD 1.11B 541.84M Sep/2025
GE HealthCare Technologies USD 4.41B 58M Sep/2025
OPKO Health USD 205.19M 11.6M Sep/2025
Zimmer Biomet Holdings USD 1.66B 17.8M Sep/2025